Topical minoxidil 5% in 90% ethanol and 5% propylene glycol
DrugOther names: Topical minoxidil 5% with 90% ethanol and 5% propylene glycol
NCT Number: NCT04090801
The study will be included 60 women with FPHL. The diagnosis of FPHL will be established by clinical (Ludwig classification) and trichoscopic evaluation of frontal and occipital regions of the scalp.
Looking for future studies?
Notify Me20 year–60 year
Female
Interventional
Phase 4
Enrolled women will be randomly assigned into 3 treatment groups: group A will apply topical minoxidil 5% in 90% ethanol and 5% propylene glycol, group B will apply topical minoxidil 5% in pure ethanol alone and group C will apply pure ethanol (placebo) twice daily.
The treatment will be continued for six months with regular visits at 3 months intervals.
The medications will be provided in bottles which were identical in shape and color, and were coded by a third party.
Both patients and investigator will be blinded to the medication. Disclosure of the codes will be done, by a third party, at the end of the study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Topical minoxidil 5% with 90% ethanol and 5% propylene glycol
The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.
Other names: Topical minoxidil 5%
The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.
Time frame: 0-6 months
The 3 grades will be defined. Grade 1, (Thinning of hair is seen mainly over the anterior part of the crown with minimal widening of the parting width). Grade 2, (Thinning of the crown becomes more evident because of an increase in the number of thin and short hairs). Grade 3, (The crown becomes almost total bald, but the frontal hair line is still maintained).
Time frame: 0-6 months
It will be evaluated signs of hair changes such as hair diameter diversity.
Sohag University
Other
Minoxidil in Treatment of Androgenetic Alopecia
Acronym: FPHL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07096323
Female Pattern Hair Loss
Cairo, Egypt
View Trial DetailsNCT02206802
Alopecia, Female Pattern Hair Loss
Tucson, Arizona, United States
View Trial DetailsNCT00175617
Female Pattern Hair Loss
Vancouver, British Columbia, Canada
View Trial DetailsNCT01900041
Alopecia, Androgenetic Alopecia (AGA)
Moscow, Russia
View Trial Details